| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Albumin(King Edward Medical University) | Phase 3 Clinical | King Edward Medical University | Burns | Details | |
| Hyperoncotic human albumin | Phase 3 Clinical | Manchester University Nhs Foundation Trust | Sepsis; Shock, Septic | Details | |
| Gocatamig | HPN-328; MK-6070; DS-3280 | Phase 2 Clinical | Harpoon Therapeutics | Carcinoma, Neuroendocrine; Small Cell Lung Carcinoma | Details |
| Albumin(Tianjin Huanhu Hospital) | Phase 2 Clinical | Tianjin Huanhu Hospital | Arterial Occlusive Diseases; Hypoproteinemia; Ischemic Stroke | Details | |
| Human Albumin (European Foundation for Study of Chronic Liver Failure) | Phase 2 Clinical | European Foundation For Chronic Liver Failure | Acute-On-Chronic Liver Failure; Liver Cirrhosis | Details | |
| Human albumin (Baylor College of Medicine) | Phase 2 Clinical | Baylor College Of Medicine | Ascites | Details | |
| Tarperprumig | ALXN-1820 | Phase 2 Clinical | Alexion Pharmaceuticals Inc | Anemia, Sickle Cell; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Details |
| ND-021 | ND-021; NM21-1480; CS-2006; CS2006 | Phase 1 Clinical | Cstone Pharmaceuticals, Numab Therapeutics Ag | Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Colorectal Neoplasms; Fallopian Tube Neoplasms; Neoplasms; Peritoneal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Triple Negative Breast Neoplasms | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Human albumin (Hebei Da'an Pharmaceutical) | Approved | Hebei Daan Pharmaceutical Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Hebei Daan Pharmaceutical Co Ltd | 2002-01-31 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| 20% Human albumin (Hemarus Therapeutics) | Approved | Hemarus Therapeutics | Hemalb | India | Hypoalbuminemia; Hypovolemia; Respiratory Distress Syndrome, Adult; Nephrotic Syndrome | Hemarus Therapeutics | 2015-08-01 | Hypoalbuminemia; Hypovolemia; Nephrotic Syndrome; Respiratory Distress Syndrome, Adult | Details | |
| Human albumin (Guizhou Taibang Biological Products) | Approved | Guizhou Taibang Biological Products Co Ltd | Mainland China | Respiratory Distress Syndrome, Adult; Fibrosis; Shock, Hemorrhagic | Guizhou Taibang Biological Products Co Ltd | 1998-01-01 | Fibrosis; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| Ozoralizumab | PF-5230896; ATN-103; PF-05230896; TS-152 | Approved | Ablynx Nv | ナノゾラ, Nanozora | Japan | Arthritis, Rheumatoid | Taisho Pharmaceutical Co Ltd | 2022-09-26 | Arthritis, Rheumatoid | Details |
| Human albumin (Hualan Biological Engineering) | Approved | Hualan Ankang Biotechnology Co Ltd | Mainland China | Anemia, Hemolytic, Autoimmune; Hypoalbuminemia; Hemorrhage; Hypovolemia | Hualan Genetic Engineering Co Ltd | 1995-01-01 | Anemia, Hemolytic, Autoimmune; Hemorrhage; Hypoalbuminemia; Hypovolemia | Details | ||
| Human Albumin(Guangdong Danxia) | Approved | Guangdong Danxia Biological Pharmaceutical Co Ltd | Mainland China | Hypovolemia | Guangdong Danxia Biological Pharmaceutical Co Ltd | 2012-10-30 | Hypovolemia | Details | ||
| Human Albumin(Anhui Da'An) | Approved | Tonrol Bio-Pharmaceutical Co Ltd | Mainland China | Tonrol Bio-Pharmaceutical Co Ltd | 2002-01-31 | Details | ||||
| Human Albumin(Huhan Nanyue) | Approved | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | Mainland China | Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd | 1994-01-01 | Details | ||||
| Human albumin(Tonrol Bio-Pharmaceutical) | Approved | Tonrol Bio-Pharmaceutical Co Ltd | Mainland China | Hypovolemia | Tonrol Bio-Pharmaceutical Co Ltd | 1996-01-01 | Hypovolemia | Details | ||
| Human Albumin (SK Plasma) | Approved | Sk Plasma Co Ltd | Mainland China | Sk Plasma Co Ltd | 2010-03-15 | Details | ||||
| Human Serum Albumin (Green Cross) | Approved | Green Cross China Biological Products Co Ltd | Mainland China | Hypovolemia | Green Cross China Biological Products Co Ltd | 1998-01-01 | Hypovolemia | Details | ||
| Albumin Human(Cis Bio International) | Approved | Cis Bio International Sa | Pulmocis | EU | Cis Bio International Sa | 2020-04-06 | Details | |||
| Perfluoropropane human albumin microspheres(Hunan Jingda) | Approved | Hunan kangrun Pharmaceutical Co Ltd | Mainland China | Contrast agents | Hunan kangrun Pharmaceutical Co Ltd | 2008-10-13 | Contrast agents; Liver Diseases | Details | ||
| Albumin Human(Sanquin Plasma Products) | Approved | Sanquin Plasma Products Bv | Details | |||||||
| Albumin Human (Biotest Pharma GmbH) | Approved | Biotest Pharma Gmbh | Albiomin, Albiomin 5%, Albiomin 10% | EU | Biotest Pharma Gmbh | 2008-12-18 | Hypovolemia | Details | ||
| Human albumin(Gailifu Pharmaceutical Technology) | Approved | Grifols Medical Consulting(Shanghai)Co Ltd | Mainland China | Shock, Hemorrhagic; Edema; Ascites; Pharmaceutical aids; Hypoproteinemia; Hyperbilirubinemia, Neonatal; Respiratory Distress Syndrome, Adult; Intracranial Hypertension; Burns; Hypovolemia | Grifols Medical Consulting(Shanghai)Co Ltd | 2012-01-01 | Ascites; Burns; Edema; Hyperbilirubinemia, Neonatal; Hypoproteinemia; Hypovolemia; Intracranial Hypertension; Pharmaceutical aids; Respiratory Distress Syndrome, Adult; Shock, Hemorrhagic | Details | ||
| Human albumin(Zhengzhou Seastar Banghe Biological Pharmaceutical) | Approved | Zhengzhou Seastar Banghe Biological Pharmaceutical Co Ltd | Mainland China | Ascites; Hypoproteinemia; Hyperbilirubinemia, Neonatal; Pharmaceutical aids; Respiratory Distress Syndrome, Adult; Intracranial Hypertension; Shock; Edema | Zhengzhou Seastar Banghe Biological Pharmaceutical Co Ltd | 1999-01-01 | Ascites; Edema; Hyperbilirubinemia, Neonatal; Hypoproteinemia; Intracranial Hypertension; Pharmaceutical aids; Respiratory Distress Syndrome, Adult; Shock | Details | ||
| Vialebex (LFB SA/Swedish Orphan Biovitrum AB) | Approved | Lfb Biotechnologies Sas, Swedish Orphan Biovitrum Ag | France | Hypotension; Shock | null | 2013-02-01 | Hypotension; Shock | Details |




